The FDA has approved Spravato (esketamine) nasal spray for use as monotherapy for patients with treatment-resistant depression.
Johnson & Johnson's Spravato has been approved to treat a major ... with white blood cell count Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback